Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths.

Neppl Huber, C; Zappa, M; Coebergh, JW; Rapiti, E; Rachtan, J; Holleczek, B; Rosso, S; Aareleid, T; Brenner, H; Gondos, A and the EUNICE Survival Working Group. (2012). Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Annals of Oncology, 23 (5), 1325−1334.
ajakirjaartikkel
Neppl Huber, C; Zappa, M; Coebergh, JW; Rapiti, E; Rachtan, J; Holleczek, B; Rosso, S; Aareleid, T; Brenner, H; Gondos, A and the EUNICE Survival Working Group.
  • Inglise
Annals of Oncology
1569-8041
23
5
2012
13251334
Ilmunud
1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
WOS

Viited terviktekstile

Seotud asutused

Lisainfo

prostate cancer, prostate-specific antigen, registries, survival